| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer | VP, Clinical Development
2 companies
Yu K Peony is a Chief Medical Officer at FIBROGEN INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2020 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,350 | $41.61 | $139,393.50 | -1.7% | |
| Sep 16, 2020 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,351 | $44.01 | $147,477.51 | -1.7% | |
| Sep 3, 2020 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 10,000 | $50.89 | $508,900.00 | -4.6% | |
| Jul 24, 2020 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,351 | $42.35 | $141,914.85 | -1.6% | |
| Dec 16, 2019 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,420 | $46.68 | $159,645.60 | -1.9% | |
| Sep 16, 2019 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,419 | $40.92 | $139,905.48 | -1.9% | |
| Jun 14, 2019 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 3,420 | $40.96 | $140,083.20 | -1.8% | |
| Mar 14, 2019 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 9,145 | $56.30 | $514,863.50 | -4.8% | |
| Dec 14, 2018 | KYNB Fibrogen Inc | Chief Medical Officer | Sell | 3,422 | $38.58 | $132,020.76 | -2.3% | |
| Jul 3, 2018 | KYNB Fibrogen Inc | Chief Medical Officer | Sale+OE | 15,645 | $65.00 | $1,016,925.00 | -9.6% |